Wellington Management Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-84,273
Closed -$11.5M 2340
2017
Q3
$11.5M Buy
84,273
+5,672
+7% +$759K ﹤0.01% 1228
2017
Q2
$11.2M Buy
78,601
+4,064
+5% +$628K ﹤0.01% 1186
2017
Q1
$13.7M Sell
74,537
-41,748
-36% -$4.68M ﹤0.01% 1151
2016
Q4
$9.37M Buy
116,285
+1,250
+1% +$98.9K ﹤0.01% 1216
2016
Q3
$8.81M Sell
115,035
-8,564
-7% -$686K ﹤0.01% 1219
2016
Q2
$10.6M Buy
123,599
+61,559
+99% +$5.64M ﹤0.01% 1112
2016
Q1
$5.75M Sell
62,040
-188,601
-75% -$18.8M ﹤0.01% 1320
2015
Q4
$50.3M Buy
250,641
+5,792
+2% +$1.16M 0.01% 674
2015
Q3
$36.5M Buy
244,849
+112,293
+85% +$82.4M 0.01% 780
2015
Q2
$126M Buy
132,556
+13,149
+11% +$10.8M 0.03% 424
2015
Q1
$87.5M Buy
119,407
+37,668
+46% +$28.3M 0.02% 556
2014
Q4
$64.9M Buy
81,739
+5,983
+8% +$3.22M 0.02% 648
2014
Q3
$30.2M Sell
75,756
-1,440
-2% -$386K 0.01% 881
2014
Q2
$20.8M Sell
77,196
-3,449
-4% -$740K 0.01% 1021
2014
Q1
$17.6M Sell
80,645
-6,905
-8% -$1.92M ﹤0.01% 1077
2013
Q4
$23.7M Buy
+87,550
New +$20.9M 0.01% 950

Other funds holding TTPH

Wellington Management Group's TTPH Position: Q4 2017 in Review

Wellington Management Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2017, closing a stake of 84,273 shares — an estimated $11.5M sold.

Wellington Management Group first reported a position in TTPH in Q4 2013 and held it in 16 quarters. The position peaked at $126M in Q2 2015. 103 funds tracked by Wall St. Rank hold TTPH as of Q4 2017.

  • Wellington Management Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Wellington Management Group sold 84,273 Tetraphase Pharmaceuticals, Inc. shares in Q4 2017, an estimated $11.5M.
  • Wellington Management Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 16 quarters.
  • Wellington Management Group's Tetraphase Pharmaceuticals, Inc. position peaked at $126M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2017.

Based on Wellington Management Group's 13F filing for Q4 2017, filed 13 Feb 2018.